141 – 150 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes
(
- Contribution to journal › Article
- 2003
-
Mark
Bone loss and bone size after menopause.
(
- Contribution to journal › Article
-
Mark
New approaches to pharmacological treatment of osteoporosis.
(
- Contribution to journal › Article
-
Mark
Cost-equivalence of different osteoporotic fractures
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
(
- Contribution to journal › Article
-
Mark
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial
(
- Contribution to journal › Article
-
Mark
Risk factors for falls and fractures in elderly women. The Malmö OPRA study
2003)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Vertebral Deformity and Vertebral Fracture in the Elderly
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
(
- Contribution to journal › Article
-
Mark
Incidence of limb fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS)
(
- Contribution to journal › Article